# Medico Remedies Ltd (MEDICO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹47.84
Day Change: +1.53%
52W High: ₹59
52W Low: ₹31
Market Cap: ₹365 Cr

## Valuation
P/E: 31.4
P/B: 5.45
EPS: ₹1.4
Book Value: ₹8.07
Dividend Yield: 0%

## Returns
1Y Return: -16.53%

## Profitability
ROE: 0%
ROCE: 16.51%
Debt/Equity: 0.19
Revenue Growth: 48.6%
Profit Growth: 9.4%
EBITDA Margin: 8.45%
Operating Margin: 6.03%

## About
Medico Remedies Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Medico Remedies Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- BSE Filing: Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-18T22:59:28.754Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:28.754Z
Quant Updated: 2026-05-18T22:59:28.754Z
Sentiment Updated: 2026-05-18T22:59:28.754Z
Financials Status: current
Financials Updated: 2026-05-18T22:32:17.308Z
Financials Last Attempt: 2026-05-18T22:32:17.308Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹148.66 Cr
Operating Profit: ₹11.97 Cr (OPM 8.05%)
Net Profit: ₹10.09 Cr
Tax: ₹3.41 Cr

## Annual P&L History
FY25: Rev ₹148.66Cr | PAT ₹10.09Cr | OPM 8.05%
FY24: Rev ₹143.31Cr | PAT ₹8.29Cr | OPM 7%
FY23: Rev ₹138.5Cr | PAT ₹7.24Cr | OPM 4.98%

## Balance Sheet (FY25)
Total Assets: ₹119.8 Cr
Total Liabilities: ₹57.33 Cr
Borrowings: ₹14.7 Cr
Cash: ₹1.09 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Haresh Kapurlal Mehta, Chairman, CFO & Head of Legal
- Harshit Haresh Mehta, MD, Marketing & Export Head and Director
- Rishit Hareshbhai Mehta, Production of Technical & Quality Control Head and Whole-Time Director
- Rajesh C. Chawda, Chief Accountant
- Vidhi Ankit Shah, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/medico
Disclaimer: For research and education only. Not investment advice.